A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

Introduction of a direct-to-patient delivery model for its weight-loss drug in the United States could potentially delay its ...

A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

India has a strong pharma network, with more than 10,000 manufacturing facilities, over 3,000 pharma companies.

Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...